Allergan is a more research oriented company as compared to Valeant. Look at differences in the amount of their R and D. Valeant will suck what Allergan has achieved. I am not in favor of this.
Very good suggestion. I was thinking of that today. Vrx has lots of debt. AGN is the better company.
Amen and the Republicans have not one thing that I would consider being constructive.
Fire them once you get a chance. I sold some of my winners today in the market because
of their constant threat.
My interpretation is: need new management or co needs to be sold.
I looked at Value Line report and I am astounded they are still buying up companies. Their debt level is over 70% of capitalization. I like the cos. they have purchased but when oh when are they going to be profitable?
Last years earnings was 4.62. This years is estimated to be 6.50. Pays 1.08 dividend. Debt is 25% of capitalization. Looks good to me. I have followed this one for about five years.
Watch for some kind of change on earnings day
I think it will reach 650, though, unless they have a new product such a tv then I will retract my statement.